Chester County News and Community Website
BERWYN, PA — Panavance Therapeutics Inc. has announced groundbreaking findings this week, demonstrating the potential of their investigational drug, misetionamide (GP-2250), to tackle various forms of cancer by directly inhibiting …
Panavance Therapeutics Unveils Promising Data on Misetionamide’s Dual Cancer Targeting Mechanism Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has unveiled encouraging preliminary data from the Phase 1 portion of its OCU410 ArMaDa clinical trial, aimed at treating geographic atrophy (GA) secondary …
Ocugen Reports Promising Results from OCU410 ArMaDa Trial for Geographic Atrophy Read More
HARRISBURG, PA — The American Lung Association‘s 2024 “State of Lung Cancer” report brings a mixed bag of findings for Pennsylvania, revealing both significant strides and critical areas needing attention in …
Pennsylvania’s Battle with Lung Cancer: Progress Unveiled, Challenges Persist in 2024 Report Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has announced a groundbreaking approval of Kebilidi (eladocagene exuparvovec-tneq), marking the first gene therapy sanctioned for the treatment of aromatic L-amino …
Revolutionary Gene Therapy Approved: Kebilidi Offers New Hope for Rare Genetic Disorder Read More
WASHINGTON, D.C. — The U.S. Centers for Disease Control and Prevention (CDC) has reported the first confirmed case of clade I mpox in the United States, identified through laboratory testing …
First Clade I Mpox Case Hits U.S.: CDC Ramps Up Response and Prevention Efforts Read More
WASHINGTON, D.C. — The World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC) have reported a concerning rise in measles cases worldwide, reaching an estimated 10.3 …
Global Measles Cases Surge: WHO and CDC Urge Increased Immunization Efforts Read More
PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) has introduced a new set of guidelines aimed at aiding cancer patients in their efforts to quit smoking. This initiative …
NCCN Releases New Guidelines to Help Cancer Patients Quit Smoking Read More
WASHINGTON, D.C. — The Centers for Disease Control and Prevention (CDC) has released its latest data on sexually transmitted infections (STIs) in the United States, revealing both promising declines and persistent …
STI Trends Shifting: CDC Reports Declines Amidst Ongoing Health Challenges Read More
WASHINGTON, D.C. — The U.S. Department of Health and Human Services (HHS) has unveiled the 2021–2023 Progress Report for the Sexually Transmitted Infections (STI) National Strategic Plan, outlining the achievements and …
HHS Releases STI National Strategic Plan Progress Report and Highlights New Focus on HSV Read More
WAYNE, PA — Palvella Therapeutics, Inc. has announced the commencement of dosing in its Phase 3 SELVA trial, aimed at evaluating QTORIN™ 3.9% rapamycin anhydrous gel for treating microcystic lymphatic malformations …
Palvella Therapeutics Begins Phase 3 Trial for Microcystic Lymphatic Malformations Treatment Read More